Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid in Spine Surgery
NCT02314988Phase 3Recruiting
- Sponsor
- Columbia University
- Start
- Jun 2020
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in spinal cord injury (SCI) and Spinal deformity (2 arms), sponsored by Columbia University. Primary endpoint: Maximal drop in systemic hemoglobin concentration. Started Jun 2020; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
spinal cord injury (SCI)Spinal deformity
Beyond the preview
Go deeper on NCT02314988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02314988.